Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
Professor Christopher Knittel and the MIT Energy Initiative's Aisling O’Grady were one of 14 teams to win a grant from the Jameel World Education Lab.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
The technology of MIT alumni-founded Hosta AI creates detailed property assessments from photos.
MIT spinout Verta, founded by Manasi Vartak, SM ’14, PhD ’18, offers tools to help companies introduce, monitor, and manage machine-learning models safely and at scale.
Alumni are funneling aid and expertise to the front line in Ukraine.